Phase Ib/II-Study in Patients with metastatic castration-resistant
   Prostate Cancer (mCRPC) Phase Ib/II-Study of Pembrolizumab (MK-3475)
   Combination Therapies in Patients with mCRPC (KEYNOTE-365) - Study AP
   94/16 of the AUO

Titel:: Phase Ib/II-Study in Patients with metastatic castration-resistant Prostate Cancer (mCRPC) Phase Ib/II-Study of Pembrolizumab (MK-3475) Combination Therapies in Patients with mCRPC (KEYNOTE-365) - Study AP 94/16 of the AUO
Dokumenttyp:: Editorial Material
Autor(en):: Rexer, H.; Wuelfing, C.; Retz, M.
Zeitschriftentitel:: Urologe A
Jahr:: 2018
Band / Volume:: 57
Heft / Issue:: 1
Seitenangaben Beitrag:: 120-121
Volltext / DOI:: doi:10.1007/s00120-017-0556-4
Print-ISSN:: 0340-2592
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: